Abstract:Cancer immunotherapy has emerged as a promising strategy in the treatment of colorectal cancer, and relapse after tumor immunotherapy has attracted increasing attention. Cancer stem cells (CSCs), a small subset of tumor cells with self-renewal and differentiation capacities, are resistant to traditional therapies such as radiotherapy and chemotherapy. Recently, CSCs have been proven to be the cells driving tumor relapse after immunotherapy. However, the mutual interactions between CSCs and cancer niche immune cells are largely uncharacterized. In this review, we focus on colorectal CSCs, CSC-immune cell interactions and CSC-based immunotherapy. Colorectal CSCs are characterized by robust expression of surface markers such as CD44, CD133 and Lgr5; hyperactivation of stemness-related signaling pathways, such as the Wnt/β-catenin, Hippo/Yap1, Jak/Stat and Notch pathways; and disordered epigenetic modifications, including DNA methylation, histone modification, chromatin remodeling, and noncoding RNA action. Moreover, colorectal CSCs express abnormal levels of immune-related genes such as MHC and immune checkpoint molecules and mutually interact with cancer niche cells in multiple tumorigenesis-related processes, including tumor initiation, maintenance, metastasis and drug resistance. To date, many therapies targeting CSCs have been evaluated, including monoclonal antibodies, antibody‒drug conjugates, bispecific antibodies, tumor vaccines adoptive cell therapy, and small molecule inhibitors. With the development of CSC-/niche-targeting technology, as well as the integration of multidisciplinary studies, novel therapies that eliminate CSCs and reverse their immunosuppressive microenvironment are expected to be developed for the treatment of solid tumors, including colorectal cancer.

Cancer Stem Cell-Immune Cell Collusion in Immunotherapy.

Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells

Cancer Stemness Meets Immunity: From Mechanism to Therapy

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies

Cancer Resistance to Immunotherapy: What is the Role of Cancer Stem Cells?

Cancer stem cells: Regulation programs, immunological properties and immunotherapy

Tumor Immune Checkpoints and Their Associated Inhibitors

Immune evasion by cancer stem cells

Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs

Targeted immunotherapy to cancer stem cells: a novel strategy of anticancer immunotherapy

Cancer Stem Cell for Tumor Therapy

Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment

The Effects of Immune Microenvironment on Cancer Stem Cells

Stemness in solid malignancies: coping with immune attack

The missing link between cancer stem cells and immunotherapy

Cellular Dynamics of Tumor Microenvironment Driving Immunotherapy Resistance in Non-Small-Cell Lung Carcinoma

Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment

Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.

Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches

Targeting Cancer Stem Cells Using Immunologic Approaches